The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 169.20
Bid: 117.60
Ask: 240.00
Change: 0.00 (0.00%)
Spread: 122.40 (104.082%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 169.20
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Covid-19

24 Mar 2020 14:50

RNS Number : 4163H
Forterra plc
24 March 2020
 

FORTERRA plc

 

24 March 2020

 

Update on Covid-19

Forterra plc, a leading UK producer of manufactured masonry products, provides an update on Covid-19 and the measures it is taking to mitigate the impact on its business.

Colleagues and customers

The health, safety and wellbeing of our employees remains our primary concern and we have already taken prompt action to allow our colleagues to work from home wherever possible and eliminated all unnecessary travel.

In light of the new Government guidance, and in order to protect our workforce, the Board has decided to suspend all business operations as soon as possible until further notice. In some cases shutting down our facilities in a controlled and safe manner will take several days, and we will take all necessary measures to ensure our factories can efficiently resume production at the appropriate time.

The Board welcomes the Government's announcement that funding will be available to ensure employees can still be paid a proportion of their salary during a period of furlough and anticipates making use of this facility.

Balance sheet and liquidity

The Group enters this uncertain time with a strong balance sheet. We ended 2019 with net debt (pre IFRS 16) of £43.2m. This represents a multiple of 0.6 times EBITDA on a pre IFRS 16 basis.

The Group has access to a £150m revolving credit facility extending to July 2022. In recent days the Group has taken the precautionary action of drawing this facility. At the present time the Group has cash reserves of c£70m and access to an undrawn overdraft facility of £10m. In addition, the Group's credit agreement includes a £50m uncommitted accordion facility on the same terms as the main facility.

We are in regular discussion with the Company's lenders, all of whom remain supportive, to understand what future funding options may be available to the Company in light of recent Government announcements.

Actions

Given the unprecedented level of uncertainty we now face with significant economic disruption ahead, the Board has taken several immediate actions to protect the Group's liquidity position including:

Cost reduction and cash preservation: Prior to the decision to temporarily cease operations we had already taken actions to halt all non-essential discretionary expenditure. Existing commitments for capital expenditure will be honoured although we expect our suppliers and contractors to also face significant disruption in the coming months. No new commitments will be entered into. The Board remains committed to the completion of the new Desford brick factory although the phasing of expenditure will be flexed according to circumstance.

2019 final dividend suspended: Our recent full year results announcement stated that the Board would propose the payment of a final dividend of 7.5 pence per share. If approved by shareholders at the AGM this would lead to a cash outflow of c£15m in July. Whilst the Board recognises the importance of the dividend to shareholders, in the current circumstances the Board feels that it is no longer appropriate to make this payment and this resolution will be removed from the AGM notice sent to shareholders in the coming weeks.

At this stage the Board is unable to quantify what impact Covid-19 and the actions we are taking will have on the 2020 results and as such is currently unable to provide meaningful guidance on future earnings.

Upcoming AGM

The Company's AGM is currently scheduled for 14 May 2020. This is being kept under review and a further announcement will be made in due course.

Enquiries:

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO) / Ben Guyatt (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDUSSSRRWUOUAR
Date   Source Headline
22nd Aug 20227:00 amRNSTransaction in Own Shares
19th Aug 20227:00 amRNSTransaction in Own Shares
18th Aug 20227:00 amRNSTransaction in Own Shares
17th Aug 20227:00 amRNSTransaction in Own Shares
16th Aug 20227:00 amRNSTransaction in Own Shares
15th Aug 20227:00 amRNSTransaction in Own Shares
12th Aug 20227:00 amRNSTransaction in Own Shares
11th Aug 20227:00 amRNSTransaction in Own Shares
10th Aug 202210:58 amRNSDirector/PDMR Shareholding
10th Aug 20227:00 amRNSTransaction in Own Shares
9th Aug 20227:00 amRNSTransaction in Own Shares
8th Aug 20227:00 amRNSTransaction in Own Shares
5th Aug 20227:00 amRNSTransaction in Own Shares
4th Aug 20224:23 pmRNSHolding(s) in Company
4th Aug 20227:00 amRNSTransaction in Own Shares
3rd Aug 20227:00 amRNSTransaction in Own Shares
2nd Aug 20222:24 pmRNSEmployee Benefit Trust Share Purchase
1st Aug 20227:00 amRNSTransaction in Own Shares
29th Jul 20225:25 pmRNSTotal Voting Rights
29th Jul 20227:00 amRNSTransaction in Own Shares
28th Jul 20227:00 amRNSHalf-year Report
28th Jul 20227:00 amRNSTransaction in Own Shares
27th Jul 20227:00 amRNSTransaction in Own Shares
26th Jul 20227:00 amRNSTransaction in Own Shares
25th Jul 20227:00 amRNSTransaction in Own Shares
22nd Jul 20227:00 amRNSTransaction in Own Shares
21st Jul 20227:00 amRNSTransaction in Own Shares
20th Jul 20227:00 amRNSTransaction in Own Shares
19th Jul 20227:00 amRNSTransaction in Own Shares
18th Jul 20227:00 amRNSTransaction in Own Shares
15th Jul 20227:00 amRNSTransaction in Own Shares
14th Jul 20227:00 amRNSTransaction in Own Shares
13th Jul 20227:00 amRNSTransaction in Own Shares
12th Jul 20227:00 amRNSTransaction in Own Shares
11th Jul 20227:00 amRNSTransaction in Own Shares
8th Jul 20227:00 amRNSTransaction in Own Shares
7th Jul 20227:00 amRNSTransaction in Own Shares
6th Jul 20224:16 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSTransaction in Own Shares
5th Jul 202210:16 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSTransaction in Own Shares
4th Jul 20224:54 pmRNSDirector/PDMR Shareholding
4th Jul 20224:47 pmRNSEmployee Benefit Trust Share Purchase
1st Jul 20227:00 amRNSTransaction in Own Shares
30th Jun 20225:27 pmRNSTotal Voting Rights and Capital
30th Jun 20227:00 amRNSTransaction in Own Shares
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:30 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSShare buyback programme
27th Jun 20224:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.